Financials data is unavailable for this security.
View more
Year on year Level Bio AB (publ) 's revenues fell -23.10%from 34.68m to 26.67m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a 326.08% reduction in net income from a loss of 2.22m to a larger loss of 9.48m.
Gross margin | 2.57% |
---|---|
Net profit margin | -50.26% |
Operating margin | -51.06% |
Return on assets | -65.05% |
---|---|
Return on equity | -111.87% |
Return on investment | -105.55% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Level Bio AB (publ) fell by 4.21m. However, Cash Flow from Investing totalled 728.20k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 5.45m for operations while cash generated from financing totalled 506.66k.
Cash flow per share | -0.1575 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0757 |
---|---|
Tangible book value per share | 0.0101 |
More ▼
Balance sheet in SEKView more
Current ratio | 1.07 |
---|---|
Quick ratio | 0.6867 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼